GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt flag Egypt · Delayed Price · Currency is EGP
63.34
+0.34 (0.54%)
At close: Dec 2, 2025

GlaxoSmithKline S.A.E Market Cap

GlaxoSmithKline S.A.E has a market cap or net worth of 5.29 billion as of December 3, 2025. Its market cap has increased by 47.03% in one year.

Market Cap
5.29B
Enterprise Value
6.21B
Revenue
3.74B
Ranking
n/a
PE Ratio
54.06
Stock Price
63.34

Market Cap Chart

Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 5.29B, an increase of 828.93%. That is a compound annual growth rate of 11.61%.

History

DateMarket Cap% Change
Dec 2, 20255.29B75.94%
Dec 31, 20243.01B1.27%
Dec 31, 20232.97B-6.84%
Dec 29, 20223.19B23.58%
Dec 30, 20212.58B82.08%
Dec 31, 20201.42B-14.17%
Dec 31, 2019 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition